Sampre Nutritions Ltd (SAMPRE)

Loading page…

Sampre Nutritions Ltd (SAMPRE) · mywealthgrid

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Zydus Wellness LimitedZYDUSWELLZYDUSWELL	₹15,695 Cr	₹18,882 Cr	₹4,537 Cr	₹596 Cr	12.9%	₹188 Cr	5%	4.8%	3.4%	106
Bikaji Foods International LimitedBIKAJIBIKAJI	₹12,637 Cr	₹12,846 Cr	₹3,075 Cr	₹413 Cr	13.7%	₹259 Cr	8.5%	20.7%	17.3%	23
The Bombay Burmah Trading Corporation LimitedBBTCBBTC	₹9,313 Cr	₹10,868 Cr	₹19,915 Cr	₹3,540 Cr	17.6%	₹1,290 Cr	12.8%	36.4%	19.6%	-7
Mrs. Bectors Food Specialities LimitedBECTORFOODBECTORFOOD	₹6,540 Cr	₹6,671 Cr	₹2,119 Cr	₹272 Cr	12.6%	₹149 Cr	6.9%	14.6%	11.6%	34
Gopal Snacks LimitedGOPALGOPAL	₹3,177 Cr	₹3,331 Cr	₹1,608 Cr	₹118 Cr	6.7%	₹84 Cr	4.9%	14.4%	16.7%	66
Adf Foods LimitedADFFOODSADFFOODS	₹3,093 Cr	₹3,101 Cr	₹718 Cr	₹137 Cr	19.1%	₹92 Cr	13.2%	21.6%	16.9%	143
Prataap Snacks LimitedDIAMONDYDDIAMONDYD	₹2,564 Cr	₹2,567 Cr	₹1,557 Cr	₹45 Cr	3.8%	₹13 Cr	1.2%	1.1%	3.1%	13
Tasty Bite Eatables LimitedTASTYBITETASTYBITE	₹2,458 Cr	₹2,492 Cr	₹540 Cr	₹74 Cr	13.7%	₹42 Cr	7.7%	17.9%	15.7%	—
Shah Foods LtdSHAHFOODSHAHFOOD	₹766 Cr	₹766 Cr	₹0 Cr	₹0 Cr	—	₹-0 Cr	—	-0.2%	-0.1%	—
Lotus Chocolate Company LtdLOTUSCHOLOTUSCHO	₹692 Cr	₹840 Cr	₹574 Cr	₹31 Cr	5.4%	₹17 Cr	3%	50.3%	33.8%	—
Ganesh Consumer Products LimitedGANESHCPGANESHCP	₹601 Cr	₹610 Cr	₹857 Cr	₹85 Cr	9.8%	₹45 Cr	4.9%	21%	14.2%	29
Nurture Well Industries LtdNWILNWIL	₹466 Cr	₹501 Cr	₹1,026 Cr	₹90 Cr	8.8%	₹67 Cr	8.2%	23.4%	19.9%	44

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	37	25	25	43
COGS	15	5	8	15
Gross profit	22	20	17	28
	18	16	21	24
	4	4	-4	5
OPM %	10.9%	16.4%	-15.4%	11%
Depreciation	2	2	2	2
Interest	2	2	2	1
	0	0	0	0
Profit before tax	0	0	-8	2
Tax	0	0	0	-1
Tax %	16.7%	0%	2%	-73%
	0	0	-8	3
PAT margin %	0.9%	2%	-30.5%	7.1%
EPS (₹)	—	—	—	1.5
EPS adjusted (₹)	0.1	0.2	-0.9	0.3
Annual report	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	Annual report for Mar 2026

₹ Cr	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	5	7	7	21	48
Reserves	—	14	15	70	60
Minority interest	—	—	—	—	0
	—	17	18	17	18
	—	6	5	8	9
Total equity & liabilities	—	44	45	115	134
	22	21	21	20	20
CWIP	—	4	6	5	5
Investments	—	0	0	74	83
	—	19	18	17	26
Total assets	—	44	45	115	134

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	1	4	0	-1
	-4	-4	-75	-3
	3	-0	75	4
Net cash flow	0	0	-0	-0
Free cash flow	-4	0	-0	-3
CFO / Operating profit %	21.7%	96.1%	—	-23.1%

Compounded sales growth

7 years: —
5 years: —
3 years: 5%
1 year: 73%

Compounded profit growth

7 years: —
5 years: —
3 years: 107%
1 year: —

Return on equity

7 years: —
5 years: —
3 years: -1%
Last year: 3%

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	59%	80.1%	66.7%	65.6%
EBITDA margin %	10.9%	16.4%	-15.4%	11%
EBIT margin %	6%	9.1%	-23.2%	6.3%
PAT margin %	0.9%	2%	-30.5%	7.1%
Working capital
Receivable days	73	98	129	112
Inventory days	169	552	249	186
Payable days	92	150	200	135
NWC days	150	500	178	163
Leverage
Current ratio	1.46	1.31	1.17	1.6
Debt to EBITDA	4.13	4.25	—	3.75
Debt to equity	0.79	0.78	0.19	0.17
Interest coverage	1.2	1.3	-2.6	2.3
Asset turnover	0.85	0.56	0.22	0.32
Return ratios
Return on assets %	0.8%	1.1%	-6.6%	2.3%
Return on capital employed %	7.1%	7.4%	-8.1%	2.8%
Return on equity %	1.7%	2.2%	-8.4%	2.9%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	37.03%	37.03%	34.99%	28.36%	28.36%	14.16%	14.16%	12.11%	12.11%	15.26%	14.04%	14.04%
	0.73%	0.73%	0.41%	0%	0%	0%	0%	0%	0%	0%	0.43%	0%
DII	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Government	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	62.24%	62.24%	64.6%	71.64%	71.64%	85.84%	85.84%	87.89%	87.89%	84.74%	85.53%	85.96%
No. of shareholders	—	—	—	—	—	—	—	—	6,538	8,890	8,560	8,947

Promoter holding down 22.99 percentage points since Sep 2023.

96 deals · 16 Mar 2022 – 20 Jul 2026

Date	Client	Type	Venue	Side	Quantity	Price	Value
20 Jul 2026	RIDDHI SIDDHI INTERNATIONAL	Bulk	BSE	Buy	6,90,000	₹7.35	₹0.51 Cr
27 Apr 2026	PALATLA BHARATH KUMAR	Bulk	BSE	Buy	8,09,530	₹18.26	₹1.48 Cr
23 Apr 2026	AKARSHIKA TRADERS LLP	Bulk	BSE	Sell	4,80,659	₹18.25	₹0.88 Cr
22 Apr 2026	MITHUN SECURITIES PRIVATE LIMITED	Bulk	BSE	Buy	5,00,000	₹19.00	₹0.95 Cr
21 Apr 2026	MITHUN SECURITIES PRIVATE LIMITED	Bulk	BSE	Buy	5,01,265	₹18.32	₹0.92 Cr
20 Apr 2026	PALATLA BHARATH KUMAR	Bulk	BSE	Buy	8,28,000	₹17.47	₹1.45 Cr
17 Apr 2026	PALATLA BHARATH KUMAR	Bulk	BSE	Buy	7,06,800	₹17.14	₹1.21 Cr
16 Apr 2026	PALATLA BHARATH KUMAR	Bulk	BSE	Buy	8,37,600	₹16.06	₹1.35 Cr
18 Feb 2026	WHITE ROCK TRADING LLP	Bulk	BSE	Buy	8,12,045	₹18.75	₹1.52 Cr
18 Feb 2026	KARANAM HARIVENKATA DURGAANILNARENDRA	Bulk	BSE	Buy	4,87,000	₹17.10	₹0.83 Cr

1–10 of 96

1 / 10

Mr. Brahma GurbaniExecutive Director-Chairperson-MD
Vamshi Srinivas VempatiChief Financial Officer
Mr. Vishal Ratan GurbaniExecutive Director
Mrs. Vanita KhatterNon-Executive - Independent Director
Mr. Nagaraju KannegantiNon-Executive - Independent Director
Mr. Kireet ModiNon-Executive - Independent Director
Mr. Pradeep Narendra PoddarNon-Executive - Non Independent Director
Mrs. Krishnama NupurCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

Ratio	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	59%	80.1%	66.7%	65.6%
EBITDA margin %	10.9%	16.4%	-15.4%	11%
EBIT margin %	6%	9.1%	-23.2%	6.3%
PAT margin %	0.9%	2%	-30.5%	7.1%
Working capital
Receivable days	73	98	129	112
Inventory days	169	552	249	186
Payable days	92	150	200	135
NWC days	150	500	178	163
Leverage
Current ratio	1.46	1.31	1.17	1.6
Debt to EBITDA	4.13	4.25	—	3.75
Debt to equity	0.79	0.78	0.19	0.17
Interest coverage	1.2	1.3	-2.6	2.3
Asset turnover	0.85	0.56	0.22	0.32
Return ratios
Return on assets %	0.8%	1.1%	-6.6%	2.3%
Return on capital employed %	7.1%	7.4%	-8.1%	2.8%
Return on equity %	1.7%	2.2%	-8.4%	2.9%

Date	Category	Subject	Filing
29 May 2026, 5:40 pm	Board Meeting Outcome of Board Meeting	Board Meeting Outcome For Audited Financial Results For The Quarter And Year Ended 31 March 2026	PDF
26 May 2026, 10:58 pm	Board Meeting	Board Meeting Intimation for Considering And Approving The Audited Standalone And Consolidated Financial Statements For The Quarter And Year Ended 31 March 2026.	PDF
12 May 2026, 3:07 pm	AGM/EGM Postal Ballot	Sampre Nutritions Ltd - 530617 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report	PDF
12 May 2026, 3:05 pm	AGM/EGM Postal Ballot	Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot	PDF
14 Apr 2026, 11:33 pm	Company Update Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018	Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018	PDF
11 Apr 2026, 12:13 pm	Company Update Newspaper Publication	Announcement under Regulation 30 (LODR)-Newspaper Publication	PDF
10 Apr 2026, 3:30 pm	AGM/EGM Postal Ballot	Shareholder Meeting / Postal Ballot-Notice of Postal Ballot	PDF
25 Mar 2026, 10:52 pm	Insider Trading / SAST Closure of Trading Window	Closure of Trading Window	PDF

Sampre Nutritions Ltd

About

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Compounded sales growth

Compounded profit growth

Return on equity

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Annual reports

Events

1

1

1

Announcements

1

1

1

Not in the F&O segment

No fund holdings on record

Announcements

Annual reports

Compounded sales growth

Compounded profit growth

Return on equity

Sampre Nutritions Ltd

About

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

Ratios

Ratio timeline

Shareholding

Quarterly record

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Annual reports

Events

Board meetings1

Stock splits1

Bonus issues1

Announcements

Board meetings1

Stock splits1

Bonus issues1

Ratio timeline

Not in the F&O segment

No fund holdings on record

Announcements

Annual reports

Quarterly record

Bulk & block deals

Board and management

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

1

1

1

1

1

1